Immunosuppressants

Results: 1821



#Item
221Macrolides / Organofluorides / Immunosuppressants / Kidney cancer / Axitinib / Renal cell carcinoma / Everolimus / Sunitinib / Protein kinase inhibitor / Chemistry / Organic chemistry / Pyridines

Public Summary Document – November 2014 PBAC Meeting 7.2 AXITINIB tablets, 1 mg & 5 mg;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
222Organic chemistry / Antifolates / Benzamides / Methotrexate / Arthritis / Autoimmune diseases / Folinic acid / Norfloxacin / Rheumatoid arthritis / Immunosuppressants / Medicine / Chemistry

Clinical Commissioning Policy: Glucarpidase for the urgent treatment of methotrexateinduced renal dysfunction Reference: NHS England B15/P/a 1

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2015-01-14 06:23:08
223Immunology / Immunosuppressants / Rheumatology / Arthritis / Monoclonal antibodies / Infliximab / Psoriatic arthritis / Rheumatoid arthritis / Anakinra / Medicine / Health / Autoimmune diseases

REMICADE® Infliximab Consumer Medicine Information What is in this leaflet This leaflet answers some common

Add to Reading List

Source URL: www.janssen.com.au

Language: English - Date: 2013-12-15 19:38:59
224Autoimmune diseases / Immunosuppressants / Arthritis / Rheumatology / Centocor / Golimumab / Infliximab / Rheumatoid arthritis / Adalimumab / Medicine / Health / Pharmacology

® SIMPONI Golimumab (rmc) Consumer Medicine Information

Add to Reading List

Source URL: www.janssen.com.au

Language: English - Date: 2014-05-06 00:24:48
225Arthritis / Autoimmune diseases / Immunosuppressants / Monoclonal antibodies / Psoriatic arthritis / Ankylosing spondylitis / TNF inhibitor / Biologic / Adalimumab / Medicine / Health / Rheumatology

Top Ten Quality Standards for Spondyloarthritis People with spondyloarthritis (SpA) evidenced by inflammatory back pain (IBP) for more than 3 months or arthritis suggestive of psoriatic arthritis, reactive arthritis or

Add to Reading List

Source URL: www.rheumatology.org.uk

Language: English - Date: 2013-02-15 09:07:18
226Immunology / Transplantation medicine / Organ transplants / Immune system / Transplant rejection / Anti-thymocyte globulin / Immunosuppressive drug / Kidney transplantation / Azathioprine / Medicine / Biology / Immunosuppressants

Transplant Rejection and Its Treatment Laurence Chan R

Add to Reading List

Source URL: www.kidneyatlas.org

Language: English - Date: 2013-08-27 14:11:30
227Immunosuppressants / Transplantation medicine / Pancreas transplantation / Diabetes / Kidney transplantation / Organ transplantation / Pancreas / Duodenum / Islets of Langerhans / Medicine / Organ transplants / Immunology

Kidney-Pancreas Transplantation John D. Pirsch Jon S. Odorico Hans W. Sollinger

Add to Reading List

Source URL: www.kidneyatlas.org

Language: English - Date: 2013-08-27 14:11:35
228Pharmacology / Immunosuppressive drug / Mycophenolic acid / Azathioprine / Sirolimus / Tacrolimus / Mycophenolate mofetil / Muromonab-CD3 / Kidney transplantation / Immunosuppressants / Medicine / Chemistry

Immunosuppressive Therapy and Protocols Angelo M. de Mattos T

Add to Reading List

Source URL: www.kidneyatlas.org

Language: English - Date: 2013-08-27 14:11:30
229Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-01 21:51:53
230Clinical research / Immunosuppressants / Science / Efalizumab / Autoimmune diseases / Progressive multifocal leukoencephalopathy / Psoriasis / Placebo / Clinical trial / Medicine / Health / Pharmacology

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 2 to Wave 1 Case Study Report 1:b:iii: Efalizumab Multi-Criteria Decision Analysis: Decision

Add to Reading List

Source URL: protectbenefitrisk.eu

Language: English - Date: 2014-07-16 01:09:14
UPDATE